Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filomena Conti

Showing results (91-100 of 121) with videos related to

Pageof 13
Sort By:
JHEP Reports : Innovation in Hepatology|March 11, 2026
Long-term outcomes and temporal trends following liver transplantation for chronic liver disease in the intensive care unitMagdalena Meszaros, José Ursic-Bedoya, Audrey Coilly, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 7, 2024
Recipient age influences survival after liver transplant: Results of the French national cohort 2007-2017Lea Lerosey, Elea Ksiasek, Michal Abrahamowicz, et al.
Clinics and Research in Hepatology and Gastroenterology|February 26, 2021
Covid-19 in liver transplant recipients: the French SOT COVID registryJérôme Dumortier, Christophe Duvoux, Olivier Roux, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 20, 2026
Immune Checkpoint Inhibitors after liver transplantation: the role of immunosuppressive managementEleonora De Martin, Teresa Maria Antonini, Thomas Uguen, et al.
Transplantation|January 30, 2025
Should We Transplant Candidates With a Positive SARS-CoV-2 RT-PCR Test?Ilies Benotmane, Nathan Kasriel, Christophe Masset, et al.
European Journal of Clinical Pharmacology|August 7, 2019
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohortAurélie Barrail-Tran, Lauriane Goldwirt, Thibaut Gelé, et al.
Viruses|January 21, 2023
Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?Lucy Meunier, Mohamed Belkacemi, George Philippe Pageaux, et al.
Journal of Hepatology|March 23, 2024
Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC studyCatherine Lamarque, Lauriane Segaux, Philippe Bachellier, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 3, 2020
Long term results of liver transplantation for alpha-1 antitrypsin deficiencyOlivier Guillaud, Emmanuel Jacquemin, Eduardo Couchonnal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2026
Liver Transplantation for HBV-Related Disease in France: NUC Type Before LT Is Associated With Patient SurvivalIsaure Bienvenue, Olivier Roux, Audrey Coilly, et al.
Pageof 13

Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
JHEP Reports : Innovation in Hepatology|March 11, 2026
Long-term outcomes and temporal trends following liver transplantation for chronic liver disease in the intensive care unitMagdalena Meszaros, José Ursic-Bedoya, Audrey Coilly, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 7, 2024
Recipient age influences survival after liver transplant: Results of the French national cohort 2007-2017Lea Lerosey, Elea Ksiasek, Michal Abrahamowicz, et al.
Clinics and Research in Hepatology and Gastroenterology|February 26, 2021
Covid-19 in liver transplant recipients: the French SOT COVID registryJérôme Dumortier, Christophe Duvoux, Olivier Roux, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 20, 2026
Immune Checkpoint Inhibitors after liver transplantation: the role of immunosuppressive managementEleonora De Martin, Teresa Maria Antonini, Thomas Uguen, et al.
Transplantation|January 30, 2025
Should We Transplant Candidates With a Positive SARS-CoV-2 RT-PCR Test?Ilies Benotmane, Nathan Kasriel, Christophe Masset, et al.
European Journal of Clinical Pharmacology|August 7, 2019
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohortAurélie Barrail-Tran, Lauriane Goldwirt, Thibaut Gelé, et al.
Viruses|January 21, 2023
Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?Lucy Meunier, Mohamed Belkacemi, George Philippe Pageaux, et al.
Journal of Hepatology|March 23, 2024
Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC studyCatherine Lamarque, Lauriane Segaux, Philippe Bachellier, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 3, 2020
Long term results of liver transplantation for alpha-1 antitrypsin deficiencyOlivier Guillaud, Emmanuel Jacquemin, Eduardo Couchonnal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2026
Liver Transplantation for HBV-Related Disease in France: NUC Type Before LT Is Associated With Patient SurvivalIsaure Bienvenue, Olivier Roux, Audrey Coilly, et al.
Pageof 13